BCL-2 family antagonists for cancer therapy

By G. Lessene, P. Czabotar, P. Colman. Nature reviews. Drug discovery, 2008

623 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/33cba4271c94f73bbf005e735b677cee2a4b66c8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. Guido Kroemer
2. Thomas G. Cotter

In Molecular Biology

1. L. Galluzzi
2. Guido Kroemer
3. Simone Fulda
4. Thomas G. Cotter
5. Douglas R. Green
6. Beth Levine
7. Oliver Kepp
8. Rebecca S. Y. Wong

Citations in the corpus

• Apoptosis and cancer: the genesis of a research field (2009, methodology): “Progress in this area of research has recently been reviewed by Lessene et al”
• Targeting mitochondria for cancer therapy (2010, background): “BH3 mimetics that activate pro-apoptotic BCL-2-like proteins are still in preclinical stages of developmen”
• Flow cytometry: basic principles and applications (2017, background): “Active caspases-3 initiates series of events that ultimately kill a cell (Lessene et al., 2008; Wlodkowic et al., 2012).”